SGHT Earnings & Financial Statements
Sight Sciences, Inc.
$8.80
+$0.55(+6.67%)
60
Overall
55
Value
75
Tech
50
Quality
Market Cap
$454.48M
Volume
282.04K
52W Range
$3.22 - $9.71
Target Price
$9.40
SGHT earnings and financial statements: Sight Sciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SGHT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $77.36M | $79.87M | $81.06M | $71.33M | $48.96M |
| Cost of revenue | $10.70M | $11.58M | $11.88M | $12.36M | $8.61M |
| Operating income | -$37.10M | -$50.53M | -$57.27M | -$83.95M | -$51.48M |
| EBITDA | -$31.84M | -$45.14M | -$48.80M | -$81.02M | -$57.07M |
| Net income | -$38.43M | -$51.51M | -$55.55M | -$86.24M | -$62.96M |
| EPS (diluted) | $-0.74 | $-1.03 | $-1.14 | $-1.80 | $-2.36 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $115.30M | $142.84M | $166.65M | $213.07M | $280.19M |
| Total liabilities | $51.36M | $55.32M | $46.44M | $53.00M | $48.08M |
| Shareholders’ equity | $63.94M | $87.52M | $120.22M | $160.08M | $232.11M |
| Cash and equivalents | $91.97M | $120.36M | $138.13M | $185.00M | $260.69M |
| Long-term debt | $40.30M | $39.36M | $31.71M | $33.31M | $32.66M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$29.69M | -$22.35M | -$47.18M | -$75.97M | -$52.54M |
| Capital expenditure | -$224.0K | -$385.0K | -$791.0K | -$970.0K | -$813.0K |
| Free cash flow | -$29.92M | -$22.74M | -$47.98M | -$76.94M | -$53.35M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SGHT | $8.80 | +6.7% | 282.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |